Skip to main content
Sister Publication Links
  • European Rubber Journal
  • Plastics News
  • Tire Business
Subscribe
  • Login
  • Register
  • Subscribe
  • News
    • Best Places to Work
    • Rubber Division IEC
    • War in Ukraine
    • Automotive
    • Tire
    • Non-Tire
    • Suppliers
    • ITEC
    • Silicone
    • Online Exclusive
    • Latex
    • Technical Notebooks
    • Executive Action
    • Government/Legal
    • Opinion
    • Blogs
    • Sustainability
    • Products
    • Wacky World of Rubber
  • Airless Tires
  • Custom
    • Sponsored Content
    • White Papers
  • Resources
    • Directory
    • Classifieds & Mold Mart
  • Data
  • Events
    • RN Events
    • RN Livestreams/Webinars
    • Industry Events
    • Past Events
    • Rubber News M&A Live
    • Ask the Expert
    • Healthcare Elastomers Conference
    • Rubber In Automotive Conference
    • Women Breaking the Mold Networking Forum
  • Advertise
  • DIGITAL EDITION
MENU
Breadcrumb
  1. Home
  2. News
August 29, 2017 02:00 AM

Datwyler develops elastomers for tomorrow's health care market

European Rubber Journal Report
  • Tweet
  • Share
  • Share
  • Email
  • More
    Print
    Datwyler Holding A.G.
    The particle content of the air in Datwyler Pharma Packaging Division's clean room sector is continuously monitored.

    ALTDORF, Switzerland—Set against the background of an increasing demand for highly sensitive drugs such as biologics and biosimilars, the requirements for parenteral packaging and elastomer components in the contemporary health care industry are changing rapidly.

    Market trends indicate a growing demand for fluoropolymer-coated elastomeric closures, primarily to mitigate risks related to drug stability and compatibility.

    The efficacy of therapeutic proteins that are integral to biosimilars and biologics, depends on their exact chemical make-up and three-dimensional conformation. Interactions with added processing agents, such as silicone oils, can lead to the ineffectiveness or the immunogenicity of drugs, causing chemical or conformational changes and degradation or aggregation of the highly sensitive proteins.

    As a result, pharmaceutical and medical manufacturers are increasingly choosing packaging solutions that provide low particle levels and an excellent particle management.

    To meet the requirements of biologics packaging, barrier properties are no longer sufficient.

    Datwyler Holding A.G.

    In the FirstLine production the elastomeric components are manufactured in clean room conditions according to ISO 15378 quality standards.

    As interactions of proteins with silicone oil can endanger the safety and efficacy of therapeutic proteins, the reduction and elimination of silicone oil and silicone oil-based subvisible particles (SbVPs) has become a legitimate concern for pharmaceutical and medical manufacturers.

    Datwyler's Omni Flex CP (coated plunger) was the first coated syringe plunger to provide barrier properties, and eliminate the plunger as a source of silicone oil—therefore contributing to the reduction of SbVPs.

    Manufacturing standard

    Meeting the challenging needs of drug packaging has become an important concern not only for medical and pharmaceutical manufacturers, but also for suppliers. Given this consideration, Datwyler's facilities that are aligned to the "First Line" standards are designed to operate in a fully integrated good manufacturing practice (GMP) cleanroom environment. This approach serves to minimize endotoxin, bioburden, particulate and defect levels.

    Datwyler Holding A.G.

    Datwyler Pharma Packaging Division's rubber stoppers are inspected fully automatically by a camera unit for the smallest variations in quality.

    Omni-Flex coated products are exclusively produced in the state-of-the-art facilities. As it introduces the First Line manufacturing standard to the global and local markets, Datwyler is building two additional First Line aligned facilities in the U.S. and in India.

    The company's latest strategy for the health care segment also features three standardized offering categories to provide more transparency for clients: Bio Care for the most sensitive, large molecule drugs; Pharma Care for small molecule drugs which require production flexibility and optimum quality; and Med Care with a broad range of materials and technical support for medical companies.

    Letter
    to the
    Editor

    Rubber News wants to hear from its readers. If you want to express your opinion on a story or issue, email your letter to Editor Bruce Meyer at [email protected].

    Most Popular
    1
    Bridgestone harnesses polymer breakthrough for a N.A. market first
    2
    Wacky World of Rubber: The true story behind the rubber match
    3
    USW International's Tom Conway joins White House trade panel
    4
    Sumitomo Chemical ending SSBR, EPDM production
    5
    Arlanxeo plans Saudi Arabian SR production plant
    SIGN UP FOR NEWSLETTERS
    EMAIL ADDRESS

    Please enter a valid email address.

    Please enter your email address.

    Please verify captcha.

    Please select at least one newsletter to subscribe.

    Get our newsletters

    Staying current is easy with Rubber News delivered straight to your inbox, free of charge.

    Subscribe Today

    Subscribe to Rubber News to get the best coverage and leading insights in the industry.

    SUBSCRIBE
    Connect with Us
    • LinkedIn
    • Facebook
    • Twitter

    MISSION

    To serve companies in the global rubber product industry by delivering news, industry insights, opinions and technical information.

    Contact Us

    2291 Riverfront Pkwy, Suite 1000
    Cuyahoga Falls,
    OH 44221

    Customer Service:
    877-320-1726

    Resources
    • About Us
    • Digital Edition
    • Staff
    • Advertise
    • Order Reprints
    • Privacy Policy
    • Privacy Request
    • Terms of Service
    • Careers
    • Ad Choices Ad Choices
    • Sitemap
    Partner Sites
    • Tire Business
    • European Rubber Journal
    • Plastics News
    • Urethanes Technology
    • Automotive News
    • Crain Brands
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Best Places to Work
      • Rubber Division IEC
      • War in Ukraine
      • Automotive
      • Tire
      • Non-Tire
      • Suppliers
      • ITEC
      • Silicone
      • Online Exclusive
      • Latex
      • Technical Notebooks
      • Executive Action
      • Government/Legal
      • Opinion
      • Blogs
        • Products
        • Wacky World of Rubber
      • Sustainability
    • Airless Tires
    • Custom
      • Sponsored Content
      • White Papers
    • Resources
      • Directory
      • Classifieds & Mold Mart
    • Data
    • Events
      • RN Events
        • Healthcare Elastomers Conference
        • Rubber In Automotive Conference
        • Women Breaking the Mold Networking Forum
      • RN Livestreams/Webinars
      • Industry Events
      • Past Events
      • Rubber News M&A Live
      • Ask the Expert
    • Advertise
    • DIGITAL EDITION